In UK Goodwin Procter, advised on the matter. Goodwin Procter advised Closed Loop Medicine Ltd with a team including Gretchen Scott (IP&IT), Tim Worden (Picture –...
Closed Loop Medicine’s Global Co-Development Partnership with Pharmanovia
Tay’s License Agreement with VYNE Therapeutics
In UK Goodwin Procter, advised on the matter. Goodwin Procter advised Tay Therapeutics with a team including Tim Worden (Picture – Life Science & Health Care)....
Insempra’s Investment into Solena Materials
In UK Goodwin Procter, advised on the matter. Goodwin Procter advised Insempra with a team including Sophie McGrath (Picture – Corporate M&A), Tim Worden (Life Science...
Pfizer’s $525 Million Acquisition of ReViral
In UK Clifford Chance, Goodwin Procter, advised on the matter. Clifford Chance advised Pfizer with a team including Nelson Jung (Competition Law), Gareth Camp (Corporate M&A),...
EyeBio’s $65 Million Series A Financing
In UK Goodwin Procter, advised on the matter. Goodwin Procter advised Jeito Capital, Samsara BioCapital, SV Health Investors with a team including Graham Defries (Picture –...
Centauri Therapeutics’ $32 Million Series A Investment
In UK Goodwin Procter, advised on the matter. Goodwin Procter advised Boehringer Ingelheim Venture Fund LP, Evotec AG, Novo Holdings A/S with a team including Sophie...
Permira’s Investment in BPL and Kedrion
In UK Goodwin Procter, advised on the matter. Goodwin Procter advised Bio Products Laboratory, Tiancheng Investment Management with a team including Gretchen Scott (Commercial Law), Carl...
Artios Pharma Limited’s US$153 Million Series C Financing
In UK Goodwin Procter, advised on the matter. Goodwin Procter advised Omega Funds with a team including John Egan (Corporate M&A), Duncan Greenhalgh (IP&IT), Sophie McGrath...